.svg){kind=small}
Jun-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Spiked Flamingo’s mix in June 2026 tilted toward Tincture & Sublingual at 39.79% share with a month-over-month decline of 20.52% and a year-over-year dip of 4.20%, while Pre-Roll held 34.42% share but fell 47.75% MoM and 14.12% YoY. Concentrates climbed to 24.10% share with 9.37% MoM growth and 119.62% YoY expansion, as Flower contracted to 1.69% share with declines of 84.91% MoM and 35.82% YoY. This pattern implies a rebalancing away from Pre-Roll and Flower toward Concentrates, with Tincture & Sublingual still the anchor despite MoM pressure.
The shift, coupled with a category rank of 2 in Tincture & Sublingual in Nevada, suggests a positioning concentrated on two pillars: maintaining near-top placement in Tincture & Sublingual while using Concentrates’ 119.62% YoY growth and 9.37% MoM rise to offset a 47.75% MoM drop in Pre-Roll. With average prices down 22.05% YoY and the brand’s total sales down 26.20% YoY, the mix indicates a value-led tilt in Tincture & Sublingual and volume capture in Concentrates, implying that reinforcing these two categories can stabilize share as Flower’s 84.91% MoM contraction and Pre-Roll’s retreat loosen their roles in the portfolio.
Competitive Landscape
Spiked Flamingo sits at rank #2 in NV Tincture & Sublingual for June 2026, unchanged from #2 year over year, after peaking at #1 in May 2026, while Doctor Solomon's holds #1 now and held #1 a year ago as its sales fell 7.1% year over year; by contrast, City Trees remains #3 with sales up 113.3% year over year, and Vlasic Labs climbed to #4 from #9 alongside a 292.3% year-over-year sales surge. The stability at #2 alongside a brief #1 in May 2026 suggests Spiked Flamingo is entrenched in a two-horse race with Doctor Solomon's, but accelerating challengers like City Trees and Vlasic Labs indicate the window to convert the May 2026 peak into sustained leadership is narrowing.
Notable Products
Sunset Punch Infused Pre-Roll (1g) posted the steepest decline in June 2026 at -62.10% MoM while dropping to rank 6, and Fear & Loathing Infused Pre-Roll (1g) also contracted -22.19% MoM at rank 7. In contrast, Strawberry Jelly Infused Pre-Roll (1g) jumped +158.41% MoM to rank 3, signaling volatility within the same format as Pre-Rolls occupy ranks 3, 4, 6, 7, and 10 among the top ten. With Concentrates holding the top spot at rank 1 and three placements in the top ten, the mix points to a pivot toward higher-margin inhalables with sharper rotation risk in Pre-Rolls that will require tighter SKU curation and launch timing.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
